Published in Magn Reson Med on August 01, 1992
Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med (2001) 2.22
Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol (1996) 1.39
Subclinical atherosclerosis is related to lower neuronal viability in middle-aged adults: a 1H MRS study. Brain Res (2010) 0.98
H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology (1995) 0.98
The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2010) 0.89
Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. Eur Arch Psychiatry Clin Neurosci (2011) 0.88
Proton T2 measurement and quantification of lactate in brain tumors by MRS at 3 Tesla in vivo. Magn Reson Med (2014) 0.85
Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occlusion model. Brain Res (2006) 0.84
Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Metabolite 1H relaxation in normal and hyponatremic brain. Magn Reson Med (1996) 0.77
Matrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger Type. Cell Mol Neurobiol (2016) 0.76
Neuroimaging in vascular cognitive impairment: a state-of-the-art review. BMC Med (2016) 0.76
Proton magnetic resonance spectroscopy of the thalamus in patients with osteoarthritis of the hip. Bone Joint Res (2012) 0.75
A double-blind study of symptom provocation to determine food sensitivity. N Engl J Med (1990) 7.79
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 5.12
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
High frequency volume coils for clinical NMR imaging and spectroscopy. Magn Reson Med (1994) 3.33
Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol (1995) 3.06
Longitudinal volumetric MRI change and rate of cognitive decline. Neurology (2005) 2.90
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
White matter lesions impair frontal lobe function regardless of their location. Neurology (2004) 2.77
Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology (2000) 2.73
The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med (1987) 2.58
Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol Aging (2006) 2.48
CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology (2008) 2.37
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology (2002) 2.35
Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med (2001) 2.22
Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry (2002) 2.22
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
Tissue segmentation of the brain in Alzheimer disease. AJNR Am J Neuroradiol (1997) 2.10
Artifactually high coherences result from using spherical spline computation of scalp current density. Electroencephalogr Clin Neurophysiol (1991) 2.09
Zinc sulfate supplementation improves thyroid function in hypozincemic Down children. Biol Trace Elem Res (1999) 2.03
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab (1992) 1.86
Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects. Neurology (2010) 1.86
Lake Michigan fish consumption as a source of polychlorinated biphenyls in human cord serum, maternal serum, and milk. Am J Public Health (1983) 1.85
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia (2000) 1.80
Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology (2006) 1.78
Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology (1997) 1.77
Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci U S A (1984) 1.76
The flux from glucose to glutamate in the rat brain in vivo as determined by 1H-observed, 13C-edited NMR spectroscopy. J Cereb Blood Flow Metab (1990) 1.74
Removal of lipid artifacts in 1H spectroscopic imaging by data extrapolation. Magn Reson Med (1996) 1.67
Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology (2011) 1.66
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology (2011) 1.66
Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol (1999) 1.66
Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology (2004) 1.64
Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. AJNR Am J Neuroradiol (2000) 1.64
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology (2010) 1.63
Cocaine: plasma concentrations after intranasal application in man. Science (1976) 1.62
Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol (2009) 1.57
Central basis of muscle fatigue in chronic fatigue syndrome. Neurology (1993) 1.52
Reduced phase encoding in spectroscopic imaging. Magn Reson Med (1994) 1.50
Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry (2001) 1.49
Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage (2008) 1.49
Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology (1999) 1.49
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia (2004) 1.48
Quantitative spectroscopic imaging of the human brain. Magn Reson Med (1998) 1.47
Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res (2004) 1.45
1H-Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo. Proc Natl Acad Sci U S A (1985) 1.44
Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol Aging (2003) 1.42
Posterior fossa abnormalities in hereditary spastic paraparesis with spastin mutations. J Neurol Neurosurg Psychiatry (2009) 1.41
Widespread neocortical abnormalities in temporal lobe epilepsy with and without mesial sclerosis. Neuroimage (2009) 1.41
Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology (1996) 1.40
Spectroscopic imaging display and analysis. Magn Reson Imaging (1992) 1.40
Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology (1993) 1.39
A comment on the CDC study of nonsexual household transmission of AIDS and on Cameron's correction to that study. Psychol Rep (1989) 1.39
Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol (1996) 1.39
Oral cocaine: plasma concentrations and central effects. Science (1978) 1.39
Short echo spectroscopic imaging of the human brain at 7T using transceiver arrays. Magn Reson Med (2009) 1.35
Cocaine. Sci Am (1982) 1.35
Regional differences in intramyocellular lipids in humans observed by in vivo 1H-MR spectroscopic imaging. J Appl Physiol (1985) (2001) 1.33
Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol (1994) 1.31
Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology (1997) 1.31
Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol Aging (2009) 1.31
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake. NMR Biomed (2000) 1.30
Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology (2002) 1.29
Hippocampal neurochemistry, neuromorphometry, and verbal memory in nondemented older adults. Neurology (2008) 1.29
A novel k-space trajectory measurement technique. Magn Reson Med (1998) 1.27
Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol (1996) 1.27
Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging (2000) 1.26
Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol (1993) 1.26
Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology (2005) 1.26
Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology (2003) 1.25
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry (2010) 1.24
Accelerated reabsorption in the proximal tubule produced by volume depletion. J Clin Invest (1971) 1.24
Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther (1980) 1.23
31P nuclear magnetic resonance studies of high energy phosphates and pH in human muscle fatigue. Comparison of aerobic and anaerobic exercise. J Clin Invest (1988) 1.23
P50 suppression is not affected by attentional manipulations. Biol Psychiatry (1992) 1.22
Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology (2003) 1.22
Differentiation of glucose transport in human brain gray and white matter. J Cereb Blood Flow Metab (2001) 1.21